2001 Grants

• Functional Imaging of Speech in Parkinson’ Disease

• Bone Marrow Stem Cell Delivery of GDNF in MPTP Mice

• Alpha-synuclein Involvement in Transmitter Release

• Do Visual Attention and Imagery Deficits Affect Driving in Parkinsonism?

• Genetic Modulation of Clinical Course in Pathologically Proven Parkinson’s Disease

• Dopamine Receptor Dependent Subcellular Trafficking of NMDG Glutamate Receptors in Parkinson’s Disease

• Role of Endogenous Cannibinoids in L-DOPA Dykinesias

• Role of Minocycline in the Inhibition of Microglial Activation and Protection of Dopaminergic Neurons in 6-OHDA Induced Parkinsonian Animal Model

• Neural Modulation of Working Memory by Levodopa in Parkinson’s Disease

• The Effects of Tetrahydrobiopterin on Oxidative Stress and Mitochondrial Function

• Evaluation of a Large Cohort of Patients with Sporadic or Familial Parkinson’s Disease for Involvement of the Parkin Gene

• Do Mutations in the Alpha-synuclein Gene Cause Dopamine-dependent Oxidative Stress and Neurodegeneration in a Genetic Model of Parkinson’s Disease?

• Characterizing the Effects of Repetive Transcranial Magnetic Stimulation Frequency and Intensity on Cortical Excitability and Physical Fatigue in Patients with Parkinson’s Disease

• Conversion of Human Adult Bone Marrow Stem Cells into Dopamine Neurons

• Mechanisms of Programmed Cell Dealth in a Model of Parkinson’s Disease

• Multiple Target Sites for Neural Transplantation in the Rat Model of Parkinson’s Disease

• Role of CDK5 in an MPTP Model of Parkinson’s Disease

• Mitochondrial Aconitase Inactivation in MPTP Neurotoxicity

• Structural and Functional Studies of the Parkin Ubiquitin Ligase

• Effect of STN Lesions and Stimulation Upon Striatal Neurotransmitter Release in PD Models

• Neuronal Dopamine Transporter Associated Proteins (DTRAP)

• Transplantation of Neural Stem Cells into a Rat Model of Parkinson’s Disease

• An Approach to Integrate Transgenes into Desirable Locus for Inducible Expression in Dopamine Neurons

• Protein Dysfunction in Parkinsonism Stimulation of Proteolysis as a Treatment for Parkinson’s Disease

• Physiological Restoration and In Vivo Neurochemistry, Physiology and Pharmacology of Dopaminergic and Serotoninergic Neurotransmission of Striatum in Animal Models of Parkinson’s Disease

• Stem Cell Dopamine